Current filters:

Women's Health

76 to 85 of 116 results

Aspirin may lower risk of melanoma, researchers suggest


A new study has found that women who take aspirin have a reduced risk of developing melanoma - and that…

AspirinOncologyPharmaceuticalResearchWomen's Health

FDA should not approve paroxetine or gabapentin for hot flashes, says Public Citizen


A drug approved to treat depression and other mental health disorders and another designed to prevent…

DepomedgabapentinHisamitsu PharmaNorth AmericaparoxetinePharmaceuticalRegulationWomen's Health

FDA approves Shionogi's Osphena for postmenopausal women experiencing pain during sex


The US Food and Drug Administration yesterday approved Japanese drug major Shionogi's (TYO: 4507) Osphena…

North AmericaospemifeneOsphenaPharmaceuticalQuatRx PharmaRegulationShionogiWomen's Health

GAVI Alliance funds vaccines for cervical cancer in developing countries


More than 180,000 girls in eight developing countries are set to receive protection against the leading…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoPharmaceuticalRest of the WorldVaccinesWomen's Health

French medicines regulator takes Bayer acne drug Diane-35 off market


Following a recent investigation (The Pharma Letter January 29), the French medicines agency (ANSM) announced…

BayerDermatologicalsDiane-35EuropePharmaceuticalReproductiveWomen's Health

EMA to review third- and fourth-generation combined OCs; France investigates Diane-35


The European Medicines Agency has been asked by France to review third- and fourth-generation combined…

BayerDermatologicalsDiane-35EuropePharmaceuticalRegulationReproductiveWomen's Health

76 to 85 of 116 results

Back to top